Core Viewpoint - MEDIROM MOTHER Labs has completed a private placement of new shares valued at ¥9 billion as part of its Series A funding round, involving key management members as investors to enhance business responsibility and growth motivation [1][2]. Group 1: Company Overview - MEDIROM MOTHER Labs is a subsidiary of MEDIROM Healthcare Technologies Inc., focusing on health tech, specifically through the "Lav" healthcare app and the "MOTHER Bracelet" wearable device [5]. - The company aims to provide customizable health management solutions across various sectors, including caregiving, logistics, and manufacturing [5]. Group 2: Business Strategy - The completion of the capital increase will strengthen MEDIROM MOTHER Labs' capital base, enabling accelerated development of upgraded versions of the "MOTHER Bracelet" and the establishment of systems for launching new products [3]. - The management team becoming investors is intended to enhance swift decision-making and a field-driven management structure, thereby increasing business responsibility [2]. Group 3: Future Outlook - MEDIROM MOTHER Labs plans to deliver new value in the healthcare and wellness field, driving sustainable growth both domestically and internationally [3].

Core Insights - MEDIROM Healthcare Technologies Inc. announced a second investment by Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc., in the Series A financing at a pre-money valuation of JPY9 billion (approximately US$60 million) [1] - This investment follows Mr. Hayami's initial investment in December 2024, indicating his commitment to the company's growth potential and alignment with MEDIROM's corporate philosophy [1] Company Overview - MEDIROM Mother Labs Inc. is a subsidiary of MEDIROM Healthcare Technologies Inc., focusing on the health-tech sector [6] - The company offers the "Specific Health Guidance Program" through the "Lav" health application and has developed the 24/7 recharge-free MOTHER Bracelet, which is a smart tracker [6][8] - The MOTHER Bracelet utilizes innovative technology to generate power based on temperature differences, allowing it to operate without recharging and recording key health metrics [8][9] Executive Background - Yasuhiro Hayami has a diverse career, including roles as Executive Officer at transcosmos inc. and founder of Wise, Inc., before becoming the Chief Business Officer of MEDIROM Mother Labs in 2024 [2][6]